 | • レポートコード：MRC2-11QY02550 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は抗線溶薬のグローバル市場について調査・分析したレポートです。種類別（アミノカプロン酸、アプロチニン、シクロカプロン、フィブリノーゲン、リステダ、リアスタップ、トラネキサム酸注射、トラネキサム酸経口、トラシロール）市場規模、用途別（病院、外来外科センター、診療所、医療専門プロセス、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別抗線溶薬の競争状況、市場シェア ・世界の抗線溶薬市場：種類別市場規模 2015年-2020年（アミノカプロン酸、アプロチニン、シクロカプロン、フィブリノーゲン、リステダ、リアスタップ、トラネキサム酸注射、トラネキサム酸経口、トラシロール） ・世界の抗線溶薬市場：種類別市場規模予測 2021年-2026年（アミノカプロン酸、アプロチニン、シクロカプロン、フィブリノーゲン、リステダ、リアスタップ、トラネキサム酸注射、トラネキサム酸経口、トラシロール） ・世界の抗線溶薬市場：用途別市場規模 2015年-2020年（病院、外来外科センター、診療所、医療専門プロセス、その他） ・世界の抗線溶薬市場：用途別市場規模予測 2021年-2026年（病院、外来外科センター、診療所、医療専門プロセス、その他） ・北米の抗線溶薬市場分析：米国、カナダ ・ヨーロッパの抗線溶薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの抗線溶薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の抗線溶薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの抗線溶薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Aurobindo Pharma、Acic Fine Chems、Akorn、Xanodyne Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Hemostatic agents prevent the blood loss and have the different site of action in complex coagulation and fibrinolysis pathways. Antifibrinolytic drugs inhibit the activation of plasminogen to plasmin preventing the lysis of fibrin and maintaining the clot stability. These Antifibrinolytic drugs prevent excessive bleeding.
Growth in healthcare investments, the prevalence of angioedema and growing high-risk geriatric population, are the major factors driving the global market growth for angioedema treatment. In the next few years, the demand for angioedema treatment is expected to increase significantly in the economies such as China and Japan. Rising incidence of hereditary angioedema and high awareness about treatment and the management of angioedema together drive the global hereditary angioedema market.
Market Analysis and Insights: Global Antifibrinolytic Drugs Market
The global Antifibrinolytic Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Antifibrinolytic Drugs Scope and Market Size
Antifibrinolytic Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antifibrinolytic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Antifibrinolytic Drugs market is segmented into
Aminocaproic Acid
Aprotinin
Cyklokapron
Fibrinogen
Lysteda
Riastap
Tranexamic Acid Injection
Tranexamic Acid Oral
Trasylol
Segment by Application, the Antifibrinolytic Drugs market is segmented into
Hospitals
Ambulatory Surgical Centers
Clinics
Healthcare Specialty Processes
Others
Regional and Country-level Analysis
The Antifibrinolytic Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Antifibrinolytic Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Antifibrinolytic Drugs Market Share Analysis
Antifibrinolytic Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Antifibrinolytic Drugs business, the date to enter into the Antifibrinolytic Drugs market, Antifibrinolytic Drugs product introduction, recent developments, etc.
The major vendors covered:
Aurobindo Pharma
Acic Fine Chems
Akorn
Xanodyne Pharmaceuticals
…
1 Study Coverage
1.1 Antifibrinolytic Drugs Product Introduction
1.2 Market Segments
1.3 Key Antifibrinolytic Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Antifibrinolytic Drugs Market Size Growth Rate by Type
1.4.2 Aminocaproic Acid
1.4.3 Aprotinin
1.4.4 Cyklokapron
1.4.5 Fibrinogen
1.4.6 Lysteda
1.4.7 Riastap
1.4.8 Tranexamic Acid Injection
1.4.9 Tranexamic Acid Oral
1.4.10 Trasylol
1.5 Market by Application
1.5.1 Global Antifibrinolytic Drugs Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Clinics
1.5.5 Healthcare Specialty Processes
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Antifibrinolytic Drugs Market Size, Estimates and Forecasts
2.1.1 Global Antifibrinolytic Drugs Revenue 2015-2026
2.1.2 Global Antifibrinolytic Drugs Sales 2015-2026
2.2 Global Antifibrinolytic Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Antifibrinolytic Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Antifibrinolytic Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Antifibrinolytic Drugs Competitor Landscape by Players
3.1 Antifibrinolytic Drugs Sales by Manufacturers
3.1.1 Antifibrinolytic Drugs Sales by Manufacturers (2015-2020)
3.1.2 Antifibrinolytic Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Antifibrinolytic Drugs Revenue by Manufacturers
3.2.1 Antifibrinolytic Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Antifibrinolytic Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Antifibrinolytic Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Antifibrinolytic Drugs Revenue in 2019
3.2.5 Global Antifibrinolytic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Antifibrinolytic Drugs Price by Manufacturers
3.4 Antifibrinolytic Drugs Manufacturing Base Distribution, Product Types
3.4.1 Antifibrinolytic Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antifibrinolytic Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Antifibrinolytic Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Antifibrinolytic Drugs Market Size by Type (2015-2020)
4.1.1 Global Antifibrinolytic Drugs Sales by Type (2015-2020)
4.1.2 Global Antifibrinolytic Drugs Revenue by Type (2015-2020)
4.1.3 Antifibrinolytic Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Antifibrinolytic Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Antifibrinolytic Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Antifibrinolytic Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Antifibrinolytic Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Antifibrinolytic Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Antifibrinolytic Drugs Market Size by Application (2015-2020)
5.1.1 Global Antifibrinolytic Drugs Sales by Application (2015-2020)
5.1.2 Global Antifibrinolytic Drugs Revenue by Application (2015-2020)
5.1.3 Antifibrinolytic Drugs Price by Application (2015-2020)
5.2 Antifibrinolytic Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Antifibrinolytic Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Antifibrinolytic Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Antifibrinolytic Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Antifibrinolytic Drugs by Country
6.1.1 North America Antifibrinolytic Drugs Sales by Country
6.1.2 North America Antifibrinolytic Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Antifibrinolytic Drugs Market Facts & Figures by Type
6.3 North America Antifibrinolytic Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Antifibrinolytic Drugs by Country
7.1.1 Europe Antifibrinolytic Drugs Sales by Country
7.1.2 Europe Antifibrinolytic Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Antifibrinolytic Drugs Market Facts & Figures by Type
7.3 Europe Antifibrinolytic Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Antifibrinolytic Drugs by Region
8.1.1 Asia Pacific Antifibrinolytic Drugs Sales by Region
8.1.2 Asia Pacific Antifibrinolytic Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Antifibrinolytic Drugs Market Facts & Figures by Type
8.3 Asia Pacific Antifibrinolytic Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Antifibrinolytic Drugs by Country
9.1.1 Latin America Antifibrinolytic Drugs Sales by Country
9.1.2 Latin America Antifibrinolytic Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Antifibrinolytic Drugs Market Facts & Figures by Type
9.3 Central & South America Antifibrinolytic Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Antifibrinolytic Drugs by Country
10.1.1 Middle East and Africa Antifibrinolytic Drugs Sales by Country
10.1.2 Middle East and Africa Antifibrinolytic Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Antifibrinolytic Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Antifibrinolytic Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Aurobindo Pharma
11.1.1 Aurobindo Pharma Corporation Information
11.1.2 Aurobindo Pharma Description and Business Overview
11.1.3 Aurobindo Pharma Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Aurobindo Pharma Antifibrinolytic Drugs Products Offered
11.1.5 Aurobindo Pharma Related Developments
11.2 Acic Fine Chems
11.2.1 Acic Fine Chems Corporation Information
11.2.2 Acic Fine Chems Description and Business Overview
11.2.3 Acic Fine Chems Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Acic Fine Chems Antifibrinolytic Drugs Products Offered
11.2.5 Acic Fine Chems Related Developments
11.3 Akorn
11.3.1 Akorn Corporation Information
11.3.2 Akorn Description and Business Overview
11.3.3 Akorn Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Akorn Antifibrinolytic Drugs Products Offered
11.3.5 Akorn Related Developments
11.4 Xanodyne Pharmaceuticals
11.4.1 Xanodyne Pharmaceuticals Corporation Information
11.4.2 Xanodyne Pharmaceuticals Description and Business Overview
11.4.3 Xanodyne Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Xanodyne Pharmaceuticals Antifibrinolytic Drugs Products Offered
11.4.5 Xanodyne Pharmaceuticals Related Developments
11.1 Aurobindo Pharma
11.1.1 Aurobindo Pharma Corporation Information
11.1.2 Aurobindo Pharma Description and Business Overview
11.1.3 Aurobindo Pharma Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Aurobindo Pharma Antifibrinolytic Drugs Products Offered
11.1.5 Aurobindo Pharma Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Antifibrinolytic Drugs Market Estimates and Projections by Region
12.1.1 Global Antifibrinolytic Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Antifibrinolytic Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Antifibrinolytic Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Antifibrinolytic Drugs Sales Forecast (2021-2026)
12.2.2 North America: Antifibrinolytic Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Antifibrinolytic Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Antifibrinolytic Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Antifibrinolytic Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Antifibrinolytic Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Antifibrinolytic Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Antifibrinolytic Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Antifibrinolytic Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Antifibrinolytic Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Antifibrinolytic Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Antifibrinolytic Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Antifibrinolytic Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Antifibrinolytic Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Antifibrinolytic Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Antifibrinolytic Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Antifibrinolytic Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Antifibrinolytic Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Antifibrinolytic Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Antifibrinolytic Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antifibrinolytic Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Antifibrinolytic Drugs Market Segments
Table 2. Ranking of Global Top Antifibrinolytic Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Antifibrinolytic Drugs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Aminocaproic Acid
Table 5. Major Manufacturers of Aprotinin
Table 6. Major Manufacturers of Cyklokapron
Table 7. Major Manufacturers of Fibrinogen
Table 8. Major Manufacturers of Lysteda
Table 9. Major Manufacturers of Riastap
Table 10. Major Manufacturers of Tranexamic Acid Injection
Table 11. Major Manufacturers of Tranexamic Acid Oral
Table 12. Major Manufacturers of Trasylol
Table 13. Global Antifibrinolytic Drugs Market Size Growth Rate by Application 2020-2026 (K MT)
Table 14. Global Antifibrinolytic Drugs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 15. Global Antifibrinolytic Drugs Sales by Regions 2015-2020 (K MT)
Table 16. Global Antifibrinolytic Drugs Sales Market Share by Regions (2015-2020)
Table 17. Global Antifibrinolytic Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Antifibrinolytic Drugs Sales by Manufacturers (2015-2020) (K MT)
Table 19. Global Antifibrinolytic Drugs Sales Share by Manufacturers (2015-2020)
Table 20. Global Antifibrinolytic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Antifibrinolytic Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antifibrinolytic Drugs as of 2019)
Table 22. Antifibrinolytic Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Antifibrinolytic Drugs Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Antifibrinolytic Drugs Price (2015-2020) (USD/MT)
Table 25. Antifibrinolytic Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Antifibrinolytic Drugs Product Type
Table 27. Date of International Manufacturers Enter into Antifibrinolytic Drugs Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Antifibrinolytic Drugs Sales by Type (2015-2020) (K MT)
Table 30. Global Antifibrinolytic Drugs Sales Share by Type (2015-2020)
Table 31. Global Antifibrinolytic Drugs Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Antifibrinolytic Drugs Revenue Share by Type (2015-2020)
Table 33. Antifibrinolytic Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 34. Global Antifibrinolytic Drugs Sales by Application (2015-2020) (K MT)
Table 35. Global Antifibrinolytic Drugs Sales Share by Application (2015-2020)
Table 36. North America Antifibrinolytic Drugs Sales by Country (2015-2020) (K MT)
Table 37. North America Antifibrinolytic Drugs Sales Market Share by Country (2015-2020)
Table 38. North America Antifibrinolytic Drugs Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Antifibrinolytic Drugs Revenue Market Share by Country (2015-2020)
Table 40. North America Antifibrinolytic Drugs Sales by Type (2015-2020) (K MT)
Table 41. North America Antifibrinolytic Drugs Sales Market Share by Type (2015-2020)
Table 42. North America Antifibrinolytic Drugs Sales by Application (2015-2020) (K MT)
Table 43. North America Antifibrinolytic Drugs Sales Market Share by Application (2015-2020)
Table 44. Europe Antifibrinolytic Drugs Sales by Country (2015-2020) (K MT)
Table 45. Europe Antifibrinolytic Drugs Sales Market Share by Country (2015-2020)
Table 46. Europe Antifibrinolytic Drugs Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Antifibrinolytic Drugs Revenue Market Share by Country (2015-2020)
Table 48. Europe Antifibrinolytic Drugs Sales by Type (2015-2020) (K MT)
Table 49. Europe Antifibrinolytic Drugs Sales Market Share by Type (2015-2020)
Table 50. Europe Antifibrinolytic Drugs Sales by Application (2015-2020) (K MT)
Table 51. Europe Antifibrinolytic Drugs Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Antifibrinolytic Drugs Sales by Region (2015-2020) (K MT)
Table 53. Asia Pacific Antifibrinolytic Drugs Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Antifibrinolytic Drugs Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Antifibrinolytic Drugs Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Antifibrinolytic Drugs Sales by Type (2015-2020) (K MT)
Table 57. Asia Pacific Antifibrinolytic Drugs Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Antifibrinolytic Drugs Sales by Application (2015-2020) (K MT)
Table 59. Asia Pacific Antifibrinolytic Drugs Sales Market Share by Application (2015-2020)
Table 60. Latin America Antifibrinolytic Drugs Sales by Country (2015-2020) (K MT)
Table 61. Latin America Antifibrinolytic Drugs Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Antifibrinolytic Drugs Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Antifibrinolytic Drugs Revenue Market Share by Country (2015-2020)
Table 64. Latin America Antifibrinolytic Drugs Sales by Type (2015-2020) (K MT)
Table 65. Latin America Antifibrinolytic Drugs Sales Market Share by Type (2015-2020)
Table 66. Latin America Antifibrinolytic Drugs Sales by Application (2015-2020) (K MT)
Table 67. Latin America Antifibrinolytic Drugs Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Antifibrinolytic Drugs Sales by Country (2015-2020) (K MT)
Table 69. Middle East and Africa Antifibrinolytic Drugs Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Antifibrinolytic Drugs Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Antifibrinolytic Drugs Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Antifibrinolytic Drugs Sales by Type (2015-2020) (K MT)
Table 73. Middle East and Africa Antifibrinolytic Drugs Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Antifibrinolytic Drugs Sales by Application (2015-2020) (K MT)
Table 75. Middle East and Africa Antifibrinolytic Drugs Sales Market Share by Application (2015-2020)
Table 76. Aurobindo Pharma Corporation Information
Table 77. Aurobindo Pharma Description and Major Businesses
Table 78. Aurobindo Pharma Antifibrinolytic Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 79. Aurobindo Pharma Product
Table 80. Aurobindo Pharma Recent Development
Table 81. Acic Fine Chems Corporation Information
Table 82. Acic Fine Chems Description and Major Businesses
Table 83. Acic Fine Chems Antifibrinolytic Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 84. Acic Fine Chems Product
Table 85. Acic Fine Chems Recent Development
Table 86. Akorn Corporation Information
Table 87. Akorn Description and Major Businesses
Table 88. Akorn Antifibrinolytic Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 89. Akorn Product
Table 90. Akorn Recent Development
Table 91. Xanodyne Pharmaceuticals Corporation Information
Table 92. Xanodyne Pharmaceuticals Description and Major Businesses
Table 93. Xanodyne Pharmaceuticals Antifibrinolytic Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 94. Xanodyne Pharmaceuticals Product
Table 95. Xanodyne Pharmaceuticals Recent Development
Table 96. Global Antifibrinolytic Drugs Sales Forecast by Regions (2021-2026) (K MT)
Table 97. Global Antifibrinolytic Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 98. Global Antifibrinolytic Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 99. Global Antifibrinolytic Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 100. North America: Antifibrinolytic Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 101. North America: Antifibrinolytic Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 102. Europe: Antifibrinolytic Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 103. Europe: Antifibrinolytic Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 104. Asia Pacific: Antifibrinolytic Drugs Sales Forecast by Region (2021-2026) (K MT)
Table 105. Asia Pacific: Antifibrinolytic Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 106. Latin America: Antifibrinolytic Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 107. Latin America: Antifibrinolytic Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 108. Middle East and Africa: Antifibrinolytic Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 109. Middle East and Africa: Antifibrinolytic Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 111. Key Challenges
Table 112. Market Risks
Table 113. Main Points Interviewed from Key Antifibrinolytic Drugs Players
Table 114. Antifibrinolytic Drugs Customers List
Table 115. Antifibrinolytic Drugs Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Antifibrinolytic Drugs Product Picture
Figure 2. Global Antifibrinolytic Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Aminocaproic Acid Product Picture
Figure 4. Aprotinin Product Picture
Figure 5. Cyklokapron Product Picture
Figure 6. Fibrinogen Product Picture
Figure 7. Lysteda Product Picture
Figure 8. Riastap Product Picture
Figure 9. Tranexamic Acid Injection Product Picture
Figure 10. Tranexamic Acid Oral Product Picture
Figure 11. Trasylol Product Picture
Figure 12. Global Antifibrinolytic Drugs Sales Market Share by Application in 2020 & 2026
Figure 13. Hospitals
Figure 14. Ambulatory Surgical Centers
Figure 15. Clinics
Figure 16. Healthcare Specialty Processes
Figure 17. Others
Figure 18. Antifibrinolytic Drugs Report Years Considered
Figure 19. Global Antifibrinolytic Drugs Market Size 2015-2026 (US$ Million)
Figure 20. Global Antifibrinolytic Drugs Sales 2015-2026 (K MT)
Figure 21. Global Antifibrinolytic Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 22. Global Antifibrinolytic Drugs Sales Market Share by Region (2015-2020)
Figure 23. Global Antifibrinolytic Drugs Sales Market Share by Region in 2019
Figure 24. Global Antifibrinolytic Drugs Revenue Market Share by Region (2015-2020)
Figure 25. Global Antifibrinolytic Drugs Revenue Market Share by Region in 2019
Figure 26. Global Antifibrinolytic Drugs Sales Share by Manufacturer in 2019
Figure 27. The Top 10 and 5 Players Market Share by Antifibrinolytic Drugs Revenue in 2019
Figure 28. Antifibrinolytic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Antifibrinolytic Drugs Sales Market Share by Type (2015-2020)
Figure 30. Global Antifibrinolytic Drugs Sales Market Share by Type in 2019
Figure 31. Global Antifibrinolytic Drugs Revenue Market Share by Type (2015-2020)
Figure 32. Global Antifibrinolytic Drugs Revenue Market Share by Type in 2019
Figure 33. Global Antifibrinolytic Drugs Market Share by Price Range (2015-2020)
Figure 34. Global Antifibrinolytic Drugs Sales Market Share by Application (2015-2020)
Figure 35. Global Antifibrinolytic Drugs Sales Market Share by Application in 2019
Figure 36. Global Antifibrinolytic Drugs Revenue Market Share by Application (2015-2020)
Figure 37. Global Antifibrinolytic Drugs Revenue Market Share by Application in 2019
Figure 38. North America Antifibrinolytic Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 39. North America Antifibrinolytic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. North America Antifibrinolytic Drugs Sales Market Share by Country in 2019
Figure 41. North America Antifibrinolytic Drugs Revenue Market Share by Country in 2019
Figure 42. U.S. Antifibrinolytic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 43. U.S. Antifibrinolytic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Canada Antifibrinolytic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 45. Canada Antifibrinolytic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. North America Antifibrinolytic Drugs Market Share by Type in 2019
Figure 47. North America Antifibrinolytic Drugs Market Share by Application in 2019
Figure 48. Europe Antifibrinolytic Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 49. Europe Antifibrinolytic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 50. Europe Antifibrinolytic Drugs Sales Market Share by Country in 2019
Figure 51. Europe Antifibrinolytic Drugs Revenue Market Share by Country in 2019
Figure 52. Germany Antifibrinolytic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 53. Germany Antifibrinolytic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. France Antifibrinolytic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 55. France Antifibrinolytic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. U.K. Antifibrinolytic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 57. U.K. Antifibrinolytic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Italy Antifibrinolytic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 59. Italy Antifibrinolytic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Russia Antifibrinolytic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 61. Russia Antifibrinolytic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Europe Antifibrinolytic Drugs Market Share by Type in 2019
Figure 63. Europe Antifibrinolytic Drugs Market Share by Application in 2019
Figure 64. Asia Pacific Antifibrinolytic Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 65. Asia Pacific Antifibrinolytic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 66. Asia Pacific Antifibrinolytic Drugs Sales Market Share by Region in 2019
Figure 67. Asia Pacific Antifibrinolytic Drugs Revenue Market Share by Region in 2019
Figure 68. China Antifibrinolytic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 69. China Antifibrinolytic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Japan Antifibrinolytic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 71. Japan Antifibrinolytic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. South Korea Antifibrinolytic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 73. South Korea Antifibrinolytic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. India Antifibrinolytic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 75. India Antifibrinolytic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Australia Antifibrinolytic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 77. Australia Antifibrinolytic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Taiwan Antifibrinolytic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 79. Taiwan Antifibrinolytic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Indonesia Antifibrinolytic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 81. Indonesia Antifibrinolytic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Thailand Antifibrinolytic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 83. Thailand Antifibrinolytic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Malaysia Antifibrinolytic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 85. Malaysia Antifibrinolytic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Philippines Antifibrinolytic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 87. Philippines Antifibrinolytic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Vietnam Antifibrinolytic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 89. Vietnam Antifibrinolytic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Asia Pacific Antifibrinolytic Drugs Market Share by Type in 2019
Figure 91. Asia Pacific Antifibrinolytic Drugs Market Share by Application in 2019
Figure 92. Latin America Antifibrinolytic Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 93. Latin America Antifibrinolytic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 94. Latin America Antifibrinolytic Drugs Sales Market Share by Country in 2019
Figure 95. Latin America Antifibrinolytic Drugs Revenue Market Share by Country in 2019
Figure 96. Mexico Antifibrinolytic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 97. Mexico Antifibrinolytic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Brazil Antifibrinolytic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 99. Brazil Antifibrinolytic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Argentina Antifibrinolytic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 101. Argentina Antifibrinolytic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Latin America Antifibrinolytic Drugs Market Share by Type in 2019
Figure 103. Latin America Antifibrinolytic Drugs Market Share by Application in 2019
Figure 104. Middle East and Africa Antifibrinolytic Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 105. Middle East and Africa Antifibrinolytic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 106. Middle East and Africa Antifibrinolytic Drugs Sales Market Share by Country in 2019
Figure 107. Middle East and Africa Antifibrinolytic Drugs Revenue Market Share by Country in 2019
Figure 108. Turkey Antifibrinolytic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 109. Turkey Antifibrinolytic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Saudi Arabia Antifibrinolytic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 111. Saudi Arabia Antifibrinolytic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 112. U.A.E Antifibrinolytic Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 113. U.A.E Antifibrinolytic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 114. Middle East and Africa Antifibrinolytic Drugs Market Share by Type in 2019
Figure 115. Middle East and Africa Antifibrinolytic Drugs Market Share by Application in 2019
Figure 116. North America Antifibrinolytic Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. North America Antifibrinolytic Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Europe Antifibrinolytic Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 119. Europe Antifibrinolytic Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Asia Pacific Antifibrinolytic Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 121. Asia Pacific Antifibrinolytic Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Latin America Antifibrinolytic Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 123. Latin America Antifibrinolytic Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Middle East and Africa Antifibrinolytic Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 125. Middle East and Africa Antifibrinolytic Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Porter's Five Forces Analysis
Figure 127. Channels of Distribution
Figure 128. Distributors Profiles
Figure 129. Bottom-up and Top-down Approaches for This Report
Figure 130. Data Triangulation
Figure 131. Key Executives Interviewed
血友病治療薬の世界市場（～2026年） Hemophilia is a rare disorder in which your blood doesn't clot normally because it lacks sufficient blood-clotting proteins (clotting factors). Market Analysis and Insights: Global Hemophilia Treatment Drugs Market The global Hemophilia Treatment Drugs market size is projected to reach US$ 11160 mil…- 爪囲炎治療薬の世界市場（～2026年） Paronychia usually happens when the skin around an individual's nail is irritated or harmed. Paronychia is a soft tissue infection of the skin around the fingernails and toenails. Bacteria which cause this type of infection are known as Candida. The infection begins as cellulitis but may progress to…
- 泌尿生殖器治療薬の世界市場（～2026年） A medical science concerned with the study and treatment of diseases of the genital and urinary organs, especially sexually transmitted diseases. The growing prevalence of genitourinary disorders is presumed to be the high rendering impact driver of this vertical. In addition, increasing number of p…
- 非アルコール性脂肪性肝炎（NASH）治療薬の世界市場（～2026年） Nonalcoholic steatohepatitis is a form of liver disease that develops in patients who are not alcoholic. The major feature in NASH is fat deposition in the liver, along with inflammation and damage to the liver. Most patients with NASH are not aware that they are suffering from a liver problem. Howe…
- 高脂血症処方薬の世界市場（～2026年） Market Analysis and Insights: Global Hyperlipidemia Prescription Drugs Market The global Hyperlipidemia Prescription Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Hyperlipidemia Prescription Drugs Scope and Mar…